Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
3.210
+0.170 (5.59%)
Aug 13, 2025, 4:00 PM - Market closed
Ekso Bionics Holdings Employees
As of December 31, 2024, Ekso Bionics Holdings had 66 total employees, including 61 full-time and 5 part-time employees. The number of employees decreased by 6 or -8.33% compared to the previous year.
Employees
66
Change (1Y)
-6
Growth (1Y)
-8.33%
Revenue / Employee
$221,985
Profits / Employee
-$171,379
Market Cap
8.38M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EKSO News
- 16 days ago - Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Ekso Bionics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 23 days ago - Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow - GlobeNewsWire
- 27 days ago - Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country - GlobeNewsWire
- 2 months ago - Ekso Bionics' Acceptance into NVIDIA Connect Program Bears Early Fruit - GlobeNewsWire
- 3 months ago - Ekso Bionics Announces New Effective Date of Reverse Stock Split - GlobeNewsWire
- 3 months ago - Ekso Bionics Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - Ekso Bionics Accepted into NVIDIA Connect Program - GlobeNewsWire